GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Guangzhou Kingmed Diagnostics Group Co., Ltd. Stock
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.41 CNY | -3.14% |
|
-7.01% | -29.02% |
| Sales 2023 * | 8.56B 1.18B | Sales 2024 * | 10.26B 1.42B | Capitalization | 21.49B 2.97B |
|---|---|---|---|---|---|
| Net income 2023 * | 727M 100M | Net income 2024 * | 1.15B 159M | EV / Sales 2023 * | 1.91 x |
| Net cash position 2023 * | 5.15B 712M | Net cash position 2024 * | 6.31B 871M | EV / Sales 2024 * | 1.48 x |
| P/E ratio 2023 * |
29.5
x | P/E ratio 2024 * |
18
x | Employees | 14,411 |
| Yield 2023 * |
0.89% | Yield 2024 * |
1.41% | Free-Float | 58.12% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -0.50% | ||
| 1 week | -4.00% | ||
| Current month | -18.50% | ||
| 1 month | -26.53% | ||
| 3 months | -12.87% | ||
| 6 months | -24.00% | ||
| Current year | -26.72% |
1 week
44.63
47.70
1 month
44.6361.41
Current year
44.6366.87
1 year
44.6388.49
3 years
44.63160.19
5 years
29.20178.88
10 years
9.98178.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Bi Xi Hao
DFI | Director of Finance/CFO | 54 | 10-12-31 |
Xiao Feng Zou
BRD | Director/Board Member | 44 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Ting Yan
BRD | Director/Board Member | 55 | 05-12-31 |
Zhan Wen Zeng
BRD | Director/Board Member | 58 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.63% | 2 M€ | -21.03% | - | |
| 0.41% | 2 M€ | -14.14% | ||
| 0.37% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 44.41 | -3.14% | 4 272 023 |
| 24-04-18 | 45.85 | -0.50% | 4,110,540 |
| 24-04-17 | 46.08 | -1.29% | 4,492,809 |
| 24-04-16 | 46.68 | +0.63% | 3,816,912 |
| 24-04-15 | 46.39 | +1.96% | 4,480,569 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
45.85
CNY
Average target price
77.09
CNY
Spread / Average Target
+68.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.72% | 2.97B | |
| -18.11% | 8.02B | |
| +36.93% | 3.51B | |
| -8.06% | 2.48B | |
| -14.30% | 2.23B | |
| -14.89% | 1.76B | |
| -23.12% | 1.44B | |
| -39.19% | 1.25B | |
| -11.20% | 1.11B | |
| +3.67% | 1.07B |
- Stock Market
- Equities
- 603882 Stock
